All In Biotech

Free tool

FAERS Monitor: Advair Diskus 500/50

The FDA Adverse Event Reporting System collects reports from patients, clinicians and manufacturers. Counts are unverified reports, not rates: they rise with how widely a drug is used, how long it has been sold and media attention, a report can name several drugs, and a report does not show the drug caused the event.

Last checked: Nov 20, 2026FDA FAERS (openFDA) last updated: Oct 28, 2026Methods & limitations

Reports naming NDA 021077 or its brand name (Advair Diskus 500/50, Fluticasone Propionate, Salmeterol Xinafoate). Reports on generic versions are filed under their own applications.

Reports

37,187

Serious

15,488

42% of reports

Hospitalization

8,624

Death reported

1,918

Any cause; not necessarily from the drug

Most reported reactions

MedDRA preferred terms.

  • dyspnoea5,839
  • drug ineffective4,379
  • product quality issue2,508
  • cough2,235
  • product dose omission issue2,116
  • pneumonia2,059
  • drug dose omission1,996
  • asthma1,915
  • malaise1,509
  • wrong technique in device usage process1,483
  • device use error1,445
  • chronic obstructive pulmonary disease1,308
  • underdose1,241
  • off label use1,193
  • dysphonia1,182

Reports by year received

View as table
YearReports
2004163
200579
200613
200715
200816
200934
2010328
2011624
20121,675
20134,671
20143,787
20155,405
20163,618
20173,249
20183,280
20192,604
20201,753
20211,204
20221,130
2023936
20241,089
2025586
2026925

Disproportionality screen

Proportional reporting ratio (PRR): how much more often each reaction appears in this drug's reports than in the other 21,016,972 FAERS reports. Flagged when PRR is at least 2, chi-squared at least 4 and there are 3 or more reports (Evans criteria). A screening statistic only.

ReactionReportsPRR95% CI lowerChi-squared
device use errorSignal1,44524.523.331,243
wrong technique in device usage processSignal1,48318.517.623,826
chronic obstructive pulmonary diseaseSignal1,30814.513.816,076
dysphoniaSignal1,18211.611.011,290
product quality issueSignal2,50810.610.221,586
underdoseSignal1,2419.89.29,622
asthmaSignal1,9159.79.314,820
drug dose omissionSignal1,9966.96.610,022
dyspnoeaSignal5,8395.95.724,071
coughSignal2,2354.54.46,190
product dose omission issueSignal2,1164.13.94,975
pneumoniaSignal2,0593.63.53,925
malaise1,5091.91.9709
drug ineffective4,3791.91.81,924
off label use1,1930.80.785

A high PRR for a reaction that is also the condition being treated (for example "disease progression" for a cancer drug) is expected and is not a safety signal.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.